GS
Gilead Sciences Portfolio holdings
AUM
$1.94B
1-Year Est. Return
59.93%
This Fund
S&P 500
1 Year Est. Return
+59.93%
AUM
$1.94B
AUM Growth
+$144M
(+8%)
Holding
9
Top Buys
No buys this quarter
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Arcus Biosciences
RCUS
$2.83B
| $749M | 38.69% |
31,424,760
|
|
||
2
Galapagos
GLPG
$2.19B
| $551M | 28.45% |
16,707,477
|
|
||
3
Arcellx
ACLX
$6.7B
| $438M | 22.64% |
6,720,803
|
|
||
4
Assembly Biosciences
ASMB
$451M
| $153M | 7.92% |
4,505,391
|
|
||
5
Kyverna Therapeutics
KYTX
$525M
| $38.8M | 2% |
4,126,119
|
|
||
6
Xilio Therapeutics
XLO
$39M
| $5.83M | 0.3% |
9,105,451
|
|
||
|
CYPH
7
Cypherpunk Technologies Inc
CYPH
$45M
| – | – |
-5,319,148
|
|
||
|
MRUS
8
DELISTED
Merus
MRUS
| – | – |
-452,527
|
|
||
9
Tango Therapeutics
TNGX
$2.67B
| – | – |
-4,854,443
|
|